Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- Equa Gets Go-Ahead for Additional Concurrent-Use Indications of Insulin and Other Hypoglycemic Agents: PAFSC 1st Committee
February 8, 2013
- PAFSC First Committee Recommends Approval for Japan’s First FD Treatment Acofide
February 8, 2013
- Health Sciences Council to Upgrade Committee on Immunization to “Department on Preventive Vaccination and Vaccines”
February 7, 2013
- NIHS to Accelerate Medical Innovation Research
February 7, 2013
- MHLW to Launch Panel on Feb. 14 to Set New Rules for Online OTC Drug Sales
February 6, 2013
- New Council on Conflicts of Interest Holds 1st Meeting, Some Doctors Say Disclosure of Individual Payments, Recipient Names “Hasty”
February 5, 2013
- Takeda, KAKETSUKEN Apply for Funding Under Second Project to Develop and Manufacture New Flu Vaccines
February 4, 2013
- PAFSC's 2nd Committee Recommends Approval for Arzerra
February 1, 2013
- CRO Association to Compile Guidelines for Third-Party Outsourcing after GCP Revision
February 1, 2013
- Government Allocates 9 Billion Yen in FY2013 Budget to Boost Reviews and Safety Measures of Pharmaceutical Products
January 31, 2013
- Japan Cabinet OKs FY2013 Budget, Social Security Outlays Nearly 29 Trillion Yen
January 30, 2013
- 13 Generic Makers Slapped with Improvement Order due to South Korean Supplier’s GMP Violation
January 30, 2013
- Membership of Committee on Non-Prescription Drugs to Be Evenly Split Between Medical, Pharmaceutical Communities
January 30, 2013
- Ordinary Diet Session Convenes; Bills to Amend Preventive Vaccination Law, Public Assistance Law Expected to Be Submitted
January 30, 2013
- Welfare Recipients Will Be Required to Use Generics from April 1; Those Who Request Original Drugs Will Be Asked to Give Reason
January 29, 2013
- Ministers of Health, Finance, and Internal Affairs Agree to Add 3 Vaccines to Public Vaccination Programs in April
January 29, 2013
- PAFSC First Committee on New Drugs to Discuss Approval of Japan’s First FD Treatment
January 28, 2013
- Preliminary Meetings of Regulatory Consultations Reach 331, Increase Found in Central and Peripheral Nervous System Drugs
January 25, 2013
- New Government Economic Panel Holds First Meeting, Takeda President Hasegawa Proposes to Bring Competition to Medical Industry
January 25, 2013
- Premium for New Drug Development to Be Discussed Alongside Long-Listed Drugs, Development of Drugs Used Off-Label: Health Minister Tamura
January 25, 2013
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…